NSF Antikörper (C-Term)
-
- Target Alle NSF Antikörper anzeigen
- NSF (N-Ethylmaleimide-Sensitive Factor (NSF))
-
Bindungsspezifität
- AA 668-696, C-Term
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser NSF Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Homologie
- Ha, Rat
- Aufreinigung
- This antibody is purified through a protein A column, followed by peptide affinity purification.
- Immunogen
- This NSF antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 668-696 amino acids from the C-terminal region of human NSF.
- Klon
- RB41933
- Isotyp
- Ig Fraction
- Top Product
- Discover our top product NSF Primärantikörper
-
-
- Applikationshinweise
- WB: 1:1000. WB: 1:1000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Haltbarkeit
- 6 months
-
-
Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease." in: Nature genetics, Vol. 42, Issue 9, pp. 781-5, (2010) (PubMed).
: "NSF independent fusion of Salmonella-containing late phagosomes with early endosomes." in: FEBS letters, Vol. 584, Issue 6, pp. 1251-6, (2010) (PubMed).
: "Comprehensive copy number variant (CNV) analysis of neuronal pathways genes in psychiatric disorders identifies rare variants within patients." in: Journal of psychiatric research, Vol. 44, Issue 14, pp. 971-8, (2010) (PubMed).
: "Genome-wide association study reveals genetic risk underlying Parkinson's disease...." in: Nature genetics, Vol. 41, Issue 12, pp. 1308-12, (2009) (PubMed).
: "
-
Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease." in: Nature genetics, Vol. 42, Issue 9, pp. 781-5, (2010) (PubMed).
-
- Target
- NSF (N-Ethylmaleimide-Sensitive Factor (NSF))
- Andere Bezeichnung
- NSF (NSF Produkte)
- Synonyme
- SKD2 antikoerper, AI316878 antikoerper, AU020090 antikoerper, AU067812 antikoerper, NSF antikoerper, 18.m06598 antikoerper, nsf antikoerper, si:bz18k17.1 antikoerper, wu:fj33g11 antikoerper, N-ethylmaleimide sensitive factor antikoerper, T1J1.4 antikoerper, T1J1_4 antikoerper, NEM-sensitive fusion protein antikoerper, N-ethylmaleimide sensitive factor, vesicle fusing ATPase antikoerper, N-ethylmaleimide sensitive fusion protein antikoerper, N-ethylmaleimide-sensitive factor antikoerper, N-ethylmaleimide sensitive factor antikoerper, N-ethylmaleimide-sensitive fusion protein, putative antikoerper, N-ethylmaleimide sensitive factor L homeolog antikoerper, vesicle-fusing ATPase antikoerper, N-ethylmaleimide-sensitive factor a antikoerper, AAA-type ATPase family protein antikoerper, NSF antikoerper, Nsf antikoerper, nsf antikoerper, BBOV_II007200 antikoerper, TGME49_318510 antikoerper, nsf.L antikoerper, LOC100180685 antikoerper, LOC9310886 antikoerper, nsfa antikoerper
- Hintergrund
- Required for vesicle-mediated transport. Catalyzes the fusion of transport vesicles within the Golgi cisternae. Is also required for transport from the endoplasmic reticulum to the Golgi stack. Seem to function as a fusion protein required for the delivery of cargo proteins to all compartments of the Golgi stack independent of vesicle origin.
- Molekulargewicht
- 82594
- NCBI Accession
- NP_006169
- UniProt
- P46459
-